US 10421813
Oncostatin M receptor antigen binding proteins
granted A61KA61K39/395A61P
Quick answer
US patent 10421813 (Oncostatin M receptor antigen binding proteins) held by Kiniksa Pharmaceuticals, GmbH expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kiniksa Pharmaceuticals, GmbH
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K39/395, A61P, A61P1/16, A61P1/18